Journal of Behavioral Addictions
March 26, 2024
Pedro Romero, Andrea Czakó, Wim van den Brink et al.
7 citations
Abstract Gambling disorder is a severe mental health and behavioural problem with harmful consequences, including financial, relationship and mental health problems. The present paper initiates discussion on the use of psychedelics combined with psychotherapeutic support as a potential treatment option for people living with a gambling disorder. Recent studies have shown promising results using...
JMIR Formative Research
March 4, 2024
Grant Jones, Felipe Herrmann, Adam Bear et al.
2 citations
This study demonstrates that changes in mindfulness predict subsequent changes in well-being in a data set including individuals who recently engaged in psychedelic use.
JMIR mHealth and uHealth
March 4, 2024
Christine E Callahan, Justin Kimber, Emily A. Hu et al.
18 citations
Perceived stress in the United States has drastically increased since the COVID-19 pandemic and is associated with negative mental health outcomes such as depression and anxiety. Digital mental health (DMH) interventions are efficacious tools to address negative mental health outcomes and have helped reduce the severity of psychological symptoms, such as anxiety, depression, and perceived...
Translational Psychiatry
February 27, 2024
Hanna M. Ollila, Nasa Sinnott-Armstrong, Katri Kantojärvi et al.
18 citations
Nightmares are vivid, extended, and emotionally negative or negative dreams that awaken the dreamer. While sporadic nightmares and bad dreams are common and generally harmless, frequent nightmares often reflect underlying pathologies of emotional regulation. Indeed, insomnia, depression, anxiety, or alcohol use have been associated with nightmares in epidemiological and clinical studies....
Journal of Medical Internet Research
February 20, 2024
Huijing Zou, Sek Ying Chair, Bilong Feng et al.
15 citations
Psychological distress is common among patients with acute coronary syndrome (ACS) and has considerable adverse impacts on disease progression and health outcomes. Mindfulness-based intervention is a promising complementary approach to address patients' psychological needs and promote holistic well-being. This study aims to examine the effects of a social media-based mindfulness...
BMC cardiovascular disorders
February 14, 2024
Qiongshan Chen, Hui Liu, Shizheng Du
23 citations
Hypertension and prehypertension have been widely recognized as the main contributors of global mortality. Evidence shows mindfulness-based interventions may reduce blood pressure and improve mental health. However, the effect of mindfulness-based interventions on blood pressure and mental health has not been fully understood. Potential studies published before May 24th 2023 were identified by...
Journal of Ethnopharmacology
February 10, 2024
Alberto Hernández-león, Raúl Iván Escamilla-Orozco, Aylín R. Tabal-Robles et al.
29 citations
Central nervous system (CNS) diseases can be diverse and usually present with comorbidity, as in the case of depression and anxiety. Despite alternatives like Psilocybe mushrooms for mental health there is no basic research to evidence their CNS benefits. To evaluate the anxiolytic- and antidepressant-like effects, as well as the acute toxicity of P. cubensis mushroom. First, the acute toxicity...
Journal of Ethnopharmacology
February 10, 2024
Tiago Arruda Sanchez, Lucas Rego Ramos, Felipe Araujo et al.
12 citations
Ayahuasca is a beverage used in Amazonian traditional medicine and it has been part of the human experience for millennia as well as other different psychoactive plants. Although Ayahuasca has been proposed as potentially therapeutic as an anxiolytic and antidepressant, whilst no studies have been carried out so far investigating their direct effect on brain emotional processing. This study...
Frontiers in Neuroscience
February 7, 2024
Jennifer Warner-Schmidt, Martin Stogniew, Blake Mandell et al.
6 citations
BackgroundPost-traumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder that can become chronic and debilitating when left untreated. Available pharmacotherapies are limited, take weeks to show modest benefit and remain ineffective for up to 40% of patients. Methylone is currently in clinical development for the treatment of PTSD. Preclinical studies show rapid, robust and...
British Journal of Pain
February 2024
Rémi Caron-Trahan, Anne-Eva Jusseaux, Maryse Aubin et al.
Background: Nearly a quarter of Canada's population suffers from chronic pain, a long-lasting medical condition marked by physical pain and psychological suffering. Opioids are the primary treatment for pain management in this condition; yet, this approach involves several undesirable side effects. In contrast to this established approach, non-pharmacological interventions, such as medical...